Why Berkeley Lights Fell Again Today, Despite Bullish New Analyst Notes
For the second day in a row, biotech stock Berkeley Lights (NASDAQ: BLI) suffered a big investor sell-off, falling by almost 12% on Thursday. Even though an analyst tracking the stock issued a bullish new research note on the company, it continued to experience the fallout from a sharply worded tweet storm delivered by a short seller.
Scorpion Capital's six-tweet thread was published early on Wednesday, and it accused Berkeley Lights of "fleecing" both its customers and investors of its recent IPO.
The short seller said that it interviewed 14 of the company's largest clients, all of whom conveyed that its lead product, cell analysis and processing device Beacon, "is DOA [dead on arrival] and a flop."
Source Fool.com
